SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--Averion International Corp. (OTCBB:AVRO), an international clinical research organization (CRO) specializing in oncology, cardiology, and medical devices, today announced financial results for the three and nine months ended September 30, 2007.
